Premium
DEA final rule says in‐person medical evaluation required before bupe induction
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32855
Subject(s) - interim , enforcement , administration (probate law) , operations research , law , political science , engineering
Upholding the interim final rule implementing the Ryan Haight Act from 2009, the federal Drug Enforcement Administration (DEA) has reiterated its requirement that an in‐person medical evaluation be conducted prior to induction with buprenorphine.